Eprozinol

Eprozinol
Names
	Preferred IUPAC name 3-[4-(2-Methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol
Identifiers
CAS Number	32665-36-4 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL2107691 ;
ChemSpider	109268 ;
ECHA InfoCard	100.046.482
KEGG	D07379 ;
PubChem CID	122553;
UNII	IJ21AK8IVJ ;
CompTox Dashboard (EPA)	DTXSID10865642 ;
	InChI InChI=1S/C22H30N2O2/c1-26-22(20-10-6-3-7-11-20)18-24-16-14-23(15-17-24)13-12-21(25)19-8-4-2-5-9-19/h2-11,21-22,25H,12-18H2,1H3 Key: QSRHLIUOSXVKTG-UHFFFAOYSA-N ;
	SMILES COC(CN1CCN(CC1)CCC(C2=CC=CC=C2)O)C3=CC=CC=C3;
Properties
Chemical formula	C22H30N2O2
Molar mass	354.4858
Pharmacology
ATC code	R03DX02 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Eprozinol is a drug for obstructive airway disease.^[1]^[2]

^ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
^ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.